Book Reviews | Gordon Campbell | News Flashes | Scoop Features | Scoop Video | Strange & Bizarre | Search

 


Hormone Therapy Makes Comeback--Are Cigarettes Next?

Hormone Therapy Makes Comeback--Are Cigarettes Next?

by Martha Rosenberg
November 9, 2012


Click for big version.

It has been almost ten years since a US government study found that hormone replacement therapy (HRT) did not prevent heart disease and memory loss as advertised but increased the risk of heart attacks by 29 percent and doubled the risk of dementia. Oops.

That was not all the bad news that emerged about HRT. It also increased the risk of breast cancer by 26 percent, stroke by 41 percent, doubled the risk of blood clots and increased the risk of hearing loss, gall bladder disease, urinary incontinence, asthma, the need for joint replacement, melanoma, ovarian, endometrial and lung cancers and non-Hodgkin's lymphoma, according to medical journals.

It was not exactly the fountain of youth it was billed as by hormone drug maker Wyeth (now Pfizer) in high-budget menopause awareness TV ads starring model Lauren Hutton.

In fact, HRT was such a scourge against women, in the first year that millions quit, 2003, the incidence of US breast cancer fell seven percent. It fell 15 percent among women whose tumors were fed by estrogen. Fourteen thousand women who were expected to get breast cancer didn't said news reports. And it wasn't just breast cancer women were spared: heart attack and ovarian cancer rates also fell when women quit HRT, said news reports.

The statistics must have been embarrassing to cancer researchers and public health officials. Not only was a major cause of breast cancer hidden in plain sight, the war on cancer should apparently have been a war on cancer-causing drugs!

It was even more embarrassing because the whole sequence happened before! In 1975, a Food and Drug Administration (FDA) panel found a link between Premarin (a Wyeth HRT drug) and endometrial cancer and when women quit the drug by the millions--the same thing happened. "There was a sharp downward trend in the incidence of endometrial cancer that paralleled a substantial reduction in prescriptions for replacement estrogens," reported the New England Journal of Medicine (NEJM) in 1979.

Not wanting to lose its billion dollar HRT franchise, Wyeth's medical director wrote doctors at the time that HRT still had "proven benefits" at the "the lowest maintenance dose" and that it was "simplistic indeed to attribute an apparent increase in the diagnosis of endometrial carcinoma solely to estrogen therapy."

Thirty years later, when cancer rates again dropped, Wyeth also bit back. It announced the reason women weren't seeing prevention of heart disease and memory loss from HRT was they weren't taking it soon enough. They needed to start treatment sooner. Ka-ching. The early treatment campaign was called the "timing theory."

Soon a National Institute on Aging trial and privately funded trials on "menopausal" primates, both led by Wyeth-funded investigators, were underway at major medical centers. After all, before 2002, millions of American women, perhaps the majority, had been on HRT. Wasn't there a way to get them back?

Last month the hormone revival campaign hit pay dirt. Women "who took treatments such as Pfizer Inc.'s estrogen pill Premarin within five years of menopause lowered their chance of Alzheimers by 30 percent," wrote the Washington Post about a study in the journal Neurology.

"It's really important to distinguish between studies that are able to look at early use of hormone therapy versus later use," said Pauline M. Maki, PhD on WebMD about the same study. Maki has received research support from Wyeth according to a July 2010 article in the journal Menopause. WebMD just imported a new CEO from Pfizer.

The study was funded by the National Institute on Aging (NIA) not Big Pharma. But NIA is so collegial with hormone makers, it funded the North American Menopause Society's entire 2009 annual meeting replete with Wyeth-funded doctor presenters and even Wyeth employee presenters. It also invited top Wyeth officials for a "Where Are We Now?" meeting soon after its products were linked to cancer/heart disease/blood clots/stroke/dementia.

Even if HRT did lower Alzheimer risk--would it be ethical to prescribe it in light of its other risks or even conduct trials? HRT's negative cognitive effects are so well known, a 2006 Reuters story began, "Regular exercise may prevent the mental decline associated with the long-term use of hormone replacement therapy (HRT)." And two studies in the January 13, 2009 issue of Neurology link HRT to brain shrinkage.

Hormone markers have also floated the idea that early HRT would prevent heart disease and/or cancer. But a 2011 analysis from the Million Women Study, sponsored by England's National Health Service, found women who took hormones the earliest, before or soon after the onset of menopause, were at the greatest risk of getting breast cancer.

Why does the government let--and even help--Big Pharma market HRT like it's a brand new product instead of the cause of two cancer epidemics--so far? Would anyone tell cigarette smokers to start smoking earlier?

*************

The complete story of unethical marketing of HRT to women is found in Martha Rosenberg's recent book, Born with a Junk Food Deficiency.

© Scoop Media

 
 
 
 
 
Top Scoops Headlines

 

Don Franks: Thwarting National's Tea-Break Busting Bill

National's tea break busting bill will pass through parliament this week. What will this mean? The Government's Employment Relations Amendment Bill makes several changes, including removal of guaranteed tea breaks and meal breaks. More>>

Jim Miles: Canada’s Heart Of Darkness

Once upon a time, Canada was able to create the illusion that it was the “peaceable kingdom”, an illusion accepted domestically and arguably by most of the rest of the world. This history has been well discredited with newer historical research outlining how Canada’s position as a “peacekeeper,” generally under UN auspices, remained effectively within the realm of U.S. foreign policy... More>>

ALSO:

Michael Collins: Jet Fighter Shoot Down Of MH 17 Still On Table

A senior prosecutor investigating the MH17 shoot down for the Dutch Prosecutors office, Fred Westerbeke, offered up as many questions as he did answers in an interview with SpiegelOnline yesterday. More>>

Jonathan Cook: How Israel Is Turning Gaza Into A Super-Max Prison

It is astonishing that the reconstruction of Gaza, bombed into the Stone Age according to the explicit goals of an Israeli military doctrine known as Dahiya, has tentatively only just begun two months after the end of the fighting. More>>

Binoy Kampmark: Dysfunctional Hagiography: Australia & Gough Whitlam's Death

Hagiography is the curse of the Australian Labor movement. It is a movement that searches for, and craves, mythical figures and myths. Such a phenomenon might be termed mummification, and detracts from closer examination. More>>

David Swanson: On Killing Trayvons

This Wednesday is a day of action that some are calling a national day of action against police brutality, with others adding 'and mass incarceration,' and I'd like to add 'and war' and make it global rather than national. More>>

Uri Avnery: Israel Ignoring “Tectonic Change” In Public Opinion

If the British parliament had adopted a resolution in favour of the Israeli occupation of the West Bank, the reaction of our media would have been like this: More>>

ALSO:

| UK MPs blow a “raspberry” at Netanyahu and his serfs

Byron Clark: Fiji Election: Crooks In Suits

On September 17 Fiji held its first election since Voreqe “Frank” Bainimarama seized power in a 2006 coup. With his Fiji First party receiving 59.2% of the vote, Bainimarama will remain in power. More>>

Get More From Scoop

 
 
 
 
 
 
 
Top Scoops
Search Scoop  
 
 
Powered by Vodafone
NZ independent news